Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer
出版年份 2018 全文链接
标题
Down-regulated paxillin suppresses cell proliferation and invasion by inhibiting M2 macrophage polarization in colon cancer
作者
关键词
-
出版物
BIOLOGICAL CHEMISTRY
Volume -, Issue -, Pages -
出版商
Walter de Gruyter GmbH
发表日期
2018-06-21
DOI
10.1515/hsz-2018-0002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis
- (2016) Xingwei Jiang et al. OncoImmunology
- Rectal and colon cancer: Not just a different anatomic site
- (2015) K. Tamas et al. CANCER TREATMENT REVIEWS
- Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination
- (2015) Takahisa Yamaguchi et al. Gastric Cancer
- Phosphatase and Tensin Homolog (PTEN) Represses Colon Cancer Progression through Inhibiting Paxillin Transcription via PI3K/AKT/NF-κB Pathway
- (2015) Ling-Li Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The PI3K/AKT Pathway and Renal Cell Carcinoma
- (2015) Huifang Guo et al. Journal of Genetics and Genomics
- Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma
- (2015) Oscar W.H. Yeung et al. JOURNAL OF HEPATOLOGY
- Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells
- (2015) CHUANG DU et al. ONCOLOGY REPORTS
- ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis
- (2015) M Yang et al. Cell Death & Disease
- PI3K/AKT signaling pathway and cancer: an updated review
- (2014) Miriam Martini et al. ANNALS OF MEDICINE
- MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells
- (2014) Magdalene Ameka et al. BIOCHEMICAL JOURNAL
- Induction of M2 Polarization in Primary Culture Liver Macrophages from Rats with Acute Pancreatitis
- (2014) Lixia Xu et al. PLoS One
- An optimized Protocol for Human M2 Macrophages using M-CSF and IL-4/IL-10/TGF-βYields a Dominant Immunosuppressive Phenotype
- (2014) S. Mia et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Dysregulation of the MiR-324-5p-CUEDC2 Axis Leads to Macrophage Dysfunction and Is Associated with Colon Cancer
- (2014) Yuan Chen et al. Cell Reports
- Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics
- (2013) Ichiro Kawada et al. CANCER BIOLOGY & THERAPY
- Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration
- (2013) Yuan Zhang et al. EUROPEAN JOURNAL OF CANCER
- Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
- (2013) Silke Reinartz et al. INTERNATIONAL JOURNAL OF CANCER
- M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
- (2013) Chao-Ying Liu et al. LABORATORY INVESTIGATION
- A Role for the Protein Tyrosine Phosphatase CD45 in Macrophage Adhesion through the Regulation of Paxillin Degradation
- (2013) Joëlle St-Pierre et al. PLoS One
- Diet, Genes, and Microbes
- (2013) Diane F. Birt et al. TOXICOLOGIC PATHOLOGY
- Molecular Genetics of Colorectal Cancer
- (2011) Eric R. Fearon Annual Review of Pathology-Mechanisms of Disease
- Macrophage motility requires distinct α5β1/FAK and α4β1/paxillin signaling events
- (2010) Michelle Y. Abshire et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Paxillin comes of age
- (2008) N. O. Deakin et al. JOURNAL OF CELL SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started